The diagnosis and management of rhinitis: an updated practice parameter.
- D. Wallace, M. Dykewicz, S. Tilles
- MedicineJournal of Allergy and Clinical Immunology
- 1 August 2008
Allergen immunotherapy: a practice parameter third update.
- L. Cox, H. Nelson, D. Wallace
- MedicineJournal of Allergy and Clinical Immunology
- 1 September 2007
Practice parameter for the diagnosis and management of primary immunodeficiency.
- F. Bonilla, D. Khan, D. Wallace
- MedicineJournal of Allergy and Clinical Immunology
- 11 June 2015
The diagnosis and management of anaphylaxis practice parameter: 2010 update.
- P. Lieberman, R. Nicklas, D. Wallace
- MedicineJournal of Allergy and Clinical Immunology
- 1 September 2010
The diagnosis and management of acute and chronic urticaria: 2014 update.
- J. Bernstein, D. Lang, D. Wallace
- MedicineJournal of Allergy and Clinical Immunology
- 1 May 2014
Allergy diagnostic testing: an updated practice parameter.
- I. Bernstein, James T. C. Li, R. Weber
- MedicineAnnals of Allergy, Asthma & Immunology
- 1 March 2008
Efficacy results of a trial of a herpes simplex vaccine.
In a study population that was representative of the general population of HSV-1- and HSv-2-seronegative women, the investigational vaccine was effective in preventing HSV -1 genital disease and infection but not in preventingHSV-2 disease or infection.
The underrecognized burden of influenza in young children.
- K. Poehling, K. Edwards, M. Griffin
- MedicineNew England Journal of Medicine
- 6 July 2006
Among young children, outpatient visits associated with influenza were 10 to 250 times as common as hospitalizations, and few influenza infections were recognized clinically.
Norovirus vaccine against experimental human Norwalk Virus illness.
- R. Atmar, D. Bernstein, P. Mendelman
- MedicineNew England Journal of Medicine
- 7 December 2011
This norovirus VLP vaccine provides protection against illness and infection after challenge with a homologous viral strain, Norwalk virus.
Glycoprotein-D-adjuvant vaccine to prevent genital herpes.
- L. Stanberry, S. Spruance, G. Dubin
- MedicineNew England Journal of Medicine
- 21 November 2002
BACKGROUND
An effective prophylactic vaccine would help control the spread of genital herpes.
METHODS
We conducted two double-blind, randomized trials of a herpes simplex virus type 2 (HSV-2)…
...
...